Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 24.33
+0.74 (3.14%)
May 20, 2026, 11:44 AM CST
SHE:002317 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 292.97 | 275.75 | -299.16 | 263.27 | 322.05 | 277.63 |
Depreciation & Amortization | 118.22 | 118.22 | 124.75 | 121.15 | 99.57 | 96.02 |
Other Amortization | 7.65 | 7.65 | 2.6 | 2.55 | 2.09 | 0.82 |
Loss (Gain) From Sale of Assets | -6.05 | -6.05 | -0.03 | -21.68 | -14.69 | 0.63 |
Asset Writedown & Restructuring Costs | 18.79 | 18.79 | 500.89 | 30.56 | 2.83 | 2.22 |
Loss (Gain) From Sale of Investments | 2.91 | 2.91 | -6.65 | 41.7 | -26.85 | 46.06 |
Provision & Write-off of Bad Debts | 7.78 | 7.78 | 3.21 | -1.25 | 1.79 | - |
Other Operating Activities | 151.5 | -1.44 | 2.68 | 22.6 | 80.6 | 64.79 |
Change in Accounts Receivable | -214.1 | -214.1 | -348.14 | -710.08 | -427.22 | 254.02 |
Change in Inventory | 71.24 | 71.24 | 24.19 | -39.65 | -29.94 | -54.91 |
Change in Accounts Payable | -32.85 | -32.85 | 314.51 | 524.36 | 43.89 | -48.87 |
Change in Other Net Operating Assets | 44.86 | 44.86 | 15.82 | -25.73 | - | - |
Operating Cash Flow | 475.35 | 305.2 | 337.84 | 190.61 | 63.07 | 622.77 |
Operating Cash Flow Growth | 22.30% | -9.66% | 77.24% | 202.23% | -89.87% | 348.25% |
Capital Expenditures | -310.13 | -316.17 | -228.26 | -363.06 | -267.96 | -213.76 |
Sale of Property, Plant & Equipment | 10.17 | 8.2 | 0.9 | 11.49 | 14.76 | 1.55 |
Divestitures | - | - | -0.73 | - | 0.6 | - |
Investment in Securities | -48.04 | 332.05 | 565.87 | -410.75 | -279.06 | -477.3 |
Other Investing Activities | 20.76 | 22.09 | 46.89 | 19.08 | 4.94 | 4.69 |
Investing Cash Flow | -327.25 | 46.16 | 384.67 | -743.24 | -526.73 | -684.83 |
Long-Term Debt Issued | - | 327.95 | 301.89 | 1,293 | 1,058 | 399.78 |
Total Debt Issued | 297.68 | 327.95 | 301.89 | 1,293 | 1,058 | 399.78 |
Long-Term Debt Repaid | - | -307.1 | -725.06 | -1,050 | -583.1 | -608.08 |
Total Debt Repaid | -356.7 | -307.1 | -725.06 | -1,050 | -583.1 | -608.08 |
Net Debt Issued (Repaid) | -59.02 | 20.84 | -423.17 | 243.2 | 474.89 | -208.3 |
Issuance of Common Stock | - | - | 37.08 | 590.2 | 64.06 | - |
Repurchase of Common Stock | -7.77 | -7.77 | -8.93 | -2.63 | -0.16 | -51.6 |
Common Dividends Paid | -170.37 | -170.31 | -170.95 | -171.53 | -181.42 | -186.83 |
Other Financing Activities | -132.64 | -578.29 | 3.81 | 182.49 | 0.23 | 202.37 |
Financing Cash Flow | -369.8 | -735.53 | -562.17 | 841.72 | 357.6 | -244.36 |
Foreign Exchange Rate Adjustments | -0.05 | -0.03 | 0.02 | 0.4 | 3.16 | -0.83 |
Net Cash Flow | -221.74 | -384.19 | 160.36 | 289.49 | -102.9 | -307.25 |
Free Cash Flow | 165.22 | -10.97 | 109.58 | -172.44 | -204.89 | 409 |
Free Cash Flow Growth | 8.86% | - | - | - | - | - |
Free Cash Flow Margin | 6.58% | -0.43% | 4.44% | -6.61% | -7.66% | 16.84% |
Free Cash Flow Per Share | 0.20 | -0.01 | 0.13 | -0.21 | -0.25 | 0.52 |
Cash Income Tax Paid | 195.18 | 190.38 | 225.72 | 215.77 | 206.73 | 231.56 |
Levered Free Cash Flow | - | -639.62 | 564.66 | 18.6 | -237.88 | 186.71 |
Unlevered Free Cash Flow | - | -636.5 | 580.5 | 47.92 | -192.03 | 232.85 |
Change in Working Capital | -118.41 | -118.41 | 9.55 | -268.3 | -404.32 | 134.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.